much-needed

Celsius Creditors Agree to Return Withdrawn Funds Prior to Bankruptcy In a surprising turn of events, creditors of Celsius, a...

Effective January 9, 2024: California Law Implemented to Regulate Small Business Lending Fees In a move aimed at protecting small...

Supply Chain Fund Successfully Completes First Closing, as Announced by Logistics Business® Logistics Business®, a leading publication in the logistics...

The Cleveland Cavaliers put on a dominant performance as they cruised to a resounding 140-101 victory over the Washington Wizards....

Better Markets, a non-profit organization advocating for the public interest in financial markets, recently voiced its opposition to the approval...

The RCT1100 Study: Investigating a Promising Approach for Treating Primary Ciliary Dyskinesia Primary Ciliary Dyskinesia (PCD) is a rare genetic...

Lawsuit Filed by Chicago Landlord and Business Groups to Prevent Transfer Tax Increase In a move to protect their interests...

Unconventional Drug Manufacturer Secures Over $100M Funding for Innovative PTSD Therapy Utilizing Ecstasy Post-Traumatic Stress Disorder (PTSD) affects millions of...

Credo Health, a leading healthcare technology company, has recently announced that it has secured $5.25 million in Series Seed funding....

C4X Discovery, a leading drug discovery company, is making significant strides in advancing drug discovery through its NRF2 Activator Program....

The World’s First Hydrogen Exchange Conducts Its Inaugural Transactions In a significant milestone for the renewable energy sector, the world’s...

The world of competitive gaming is constantly evolving, with new strategies and metas emerging all the time. In recent months,...

Sequana Medical, a Swiss medical device company, has recently announced that it has received Current Procedural Terminology (CPT®) III reimbursement...

Novartis, a leading pharmaceutical company, has recently announced a significant strengthening of its partnership with Voyager Therapeutics, a gene therapy...

Revumenib by Syndax Demonstrates Effectiveness in Relapsed/Refractory KMT2A-Rearranged Acute Leukemia: ASH 2023 Findings Acute leukemia is a devastating blood cancer...